Comparison of the profiles of agonists as stimulants of the β3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 580-586

  Bahl, A K ^a,b   Clayton, N M ^a   Coates, J ^a   Martin, D P ^a   Oakley, I G ^a   Strong, P ^a   Trevethick, M A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

BRL 37344; CL 316243; Gastroprotection; Ulceration; 3 adrenoceptor

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DENOPAMINE; ISOPRENALINE; SALMETEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ESOPHAGUS; ESOPHAGUS MUSCLE; FEMALE; GUINEA PIG; HEART RATE; HEART RIGHT ATRIUM; MALE; MUSCLE CONTRACTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH INJURY; STOMACH PROTECTION; TRACHEA;

EID: 0030043301     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15230.x     Document Type: Article

References (34)

1. ARCH, J.R.S., AINSWORTH, A.T., CAWTHORNE, M.A., PIERCY, V., SENNET, M.V., THODY, V.E., WILSON, C. & WILSON, S. (1984). Atypical beta-adrenoceptors on brown adipocytes as a target for anti-obesity drugs. Nature, 309, 163-165.
2. 3- and atypical β-adrenoceptors. Med. Res. Rev., 13, 663-729.
3. 2-adrenoceptor agonist: characterisation of pharmacological activity in vitro and in vivo. Br. J. Pharmacol., 104, 665-671.
4. BARKER, R.C., COLEMAN, R.A., DAHL, M.R., NIALS, A.T. & VARDEY, C.J. (1992). Do salmeterol and formoterol possess agonist activity at atypical β-adrenoceptors in guinea-pig gastric fundus? Br. J. Pharmacol., 106, 87P.
5. BIANCHETTI, A. & MANARA, L. (1990). In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon. Br. J. Pharmacol., 100, 831-839.
6. 3-adrenoceptor. Br. J. Pharmacol., 112, 911-919.
7. BLOOM, J.D., DUTIA, M.D., JOHNSON, B.S., WISSNER, A., BURNS, M.G., LARGIS, E.E., DOLAN, I.A. & CLAUS, T.A. (1992). Disodium (R,R)-5-[2-(-chlorophenyl)-2-hydroxyethyl]-amino]propyl-1,3-benzodioxole-2,2- dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent. J. Med. Chem., 35, 3081-3084.
8. CARSWELL, H. & NAHORSKI, S.R. (1983). β-Adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies. Br. J. Pharmacol., 79, 965-971.
9. COBURN, R.F. & TOMITA, T. (1973). Evidence for noradrenergic inhibitory nerves in the guinea-pig trachealis muscle. Am. J. Physiol., 222, 1072-1080.
10. CROCI, T., GIUDICE, A., BIANCHETTI, A. & MANARA, L. (1991). Colonic and cardiovascular actions of the atypical beta-adrenerige agonist SR58611A in rats. J. Gastrointest. Motil., 3, 273-279.
11. 2-subtype. Br. J. Pharmacol., 110, 442-446.
12. ESPLUGUES, J., LLORIS, J.M., MARTI-BONMATI, E. & MORCILLO, E.J. (1982). Effects of beta-adrenoceptor drug stimulation on various models of gastric ulcer in rats. Br. J. Pharmacol., 76, 587-594.
13. FIELDING, L.P., ROUTER, M. & CURWAIN, B.P. (1975). Salbutamol inhibition of gastric ulceration in the rat. Br. J. Surg., 62, 162-163.
14. FORD, A.P.D.W., TANEJA, D.T. & CLARKE, D.E. (1992), Atypical β-adrenoceptor-mediated relaxation and cyclic AMP formation in tunica muscularis mucosae (TMM) of the rat oesophagus. Br. J. Pharmacol., 105, 235P.
15. GADDUM, J.H. (1957). Theories of drug antagonism. Pharmacol. Rev., 9, 211-218.
16. GIUDICE, A., CROCI, T., BIANCHETTI, A. & MANARA, L. (1989). Inhibition of rat colonic motility and cardiovascular effects of new gut-specific beta-adrenergic phenylethanolaminotetralines. Life Sci., 44, 1411-1417.
17. HEDBERG, A., MINNEMAN, K.P. & MOLINOFF, P.B. (1980). Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. J. Pharmacol. Exp. Ther., 212, 503-508.
18. HOLLOWAY, B.R., HOWE, R., RAO, B.S. & STRIBLING, D. (1989). Selective beta-3-adrenergic agonists of brown adipose tissue and thermogenesis. In Obesity in Europe, 88. Proc. Ist Eur. Cong. Obesity. ed. Björnthorpe, P. & Rossner, S. pp. 323-328. London: John Libbey.
19. HOWARD, T.J., PASSARO, E. Jr. & GUTH, P.H. (1993). Isoproterenol prevents ethanol-induced microvascular stasis and deep histologic injury in rat gastric mucosa. Dig. Dis. Sci., 38, 1201-1209.
20. 3-adrenergic agonists. Drugs Fut., 18, 529-549.
21. JACOBSEN, E.D. (1992). Circulatory mechanisms of gastric mucosal damage and protection. Gastroenterol., 102, 1788-1800.
22. KURATANI, K., KODAMA, H. & YAMAGUCHI, I. (1994). Enhancement of gastric mucosal blood flow by beta-3 adrenergic agonists prevents indomethacin-induced antral ulcer in the rat. J. Pharmacol. Exp. Ther., 270, 559-565.
23. LAU, A.T.S., GRAHAM, G.G., DAY, R.O. & PERRY, M.A. (1992). Effect of aspirin on ulcer site blood flow in cat stomachs. Am. J. Physiol., 263, G155-G160.
24. LIVINGSTONE, E.H., HOWARD, T.J., GARRICK, T.R., PASSARO, E. & GUTH, P.H. (1991). Strong gastric contractions cause mucosal ischaemia. Am. J. Physiol., 260, G524-F530.
25. 3-adrenoceptor in man. Br. J. Pharmacol., 110, 929-936.
26. MCGEEVY, J.M. & MOODY, F.G. (1981). Focal microcirculatory changes during the production of aspirin-induced gastric mucosal lesions. Surgery St Louis., 89, 337-341.
27. MERSEREAU, W.A. & HINCHEY, E.J. (1988). Relationship between the gastric myoelectric and mechanical activity in the genesis of ulcers in indomethacin-insulin-treated rats. Dig. Dis. Sci., 33, 200-208.
28. NAGAO, T., IKEO, T., MURATA, S., SATO, M. & NAKAJIMA, H. (1984). Cardiovascular effects of a new positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]ethanol (TA-064) in the anaesthetised dog and isolated guinea-pig heart. Jpn. J. Pharmacol., 35, 415-423.
29. ROTH, S.H. & BENNETT, R.E. (1987). Non-steroidal anti-inflammatory drug gastropathy: recognition and response. Arch. Intern. Med., 147, 2093-2100.
30. SATOH, H., INADA, I., HIRATA, T. & MAKI, Y. (1981). Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology, 81, 719-725.
31. TAKEUCHI, K., SHIGERU, U. & OKABE, S. (1986). Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig. Dis. Sci., 31, 1114-1122.
32. TREVETHICK, M.A., CLAYTON, N.M., STRONG, P. & HARMAN, I. (1993). Do infiltrating neutrophils contribute to the pathogenesis of indomethacin-induced ulceration of the rat gastric antrum? Gut, 34, 156-160.
33. WILSON, C., WILSON, S., PIERCY, V., SENNITT, M.V., ARCH, J.R.S. (1984). The rat lipolytic beta-adrenoceptor. Studies using novel beta-adrenoceptor agonists. Eur. J. Pharmacol., 100, 309-319.
34. YABANA, H., NAITO, K. & NAGAO, T. (1986), Effect of chronic administration of denopamine (TA-064), a new positive inotropic agent, on cardiac response of rats to denopamine. Jpn. J. Pharmacol., 42, 87-89.